Gill Ca 2+ transport (GCAT) in fish is regulated by a number of different hormones. Stanniocalcin (STC) from the corpuscles of Stannius (CS) is an inhibitor of GCAT, whereas pituitary-derived prolactin and cortisol stimulate GCAT. Other than this, however, little is known about the effects of other hormones on this important transport process. The role of calcitonin (CT) in calcium homeostasis in fish is still controversial. Whereas many studies have shown significant effects of CT on plasma calcium levels, an equal number of studies have failed to find any correlations between plasma calcium and CT levels in fish. Previous in vitro studies have shown that salmon CT has potent inhibitory effects on GCAT in isolated, perfused fish gill preparations, a finding that has never been corroborated in vivo. Therefore, in this report we examined the effects of salmon CT on whole body 45 Ca uptake (as a measure of GCAT) in young rainbow trout. In support of the in vitro findings, we found that CT had significant inhibitory effects on GCAT. In parallel studies, we found that CT had no effects on STC secretion and only modest, stimulatory effects on STC mRNA levels in cultured trout CS cells. These finding suggest that both CT and STC function as negative regulators of GCAT in fish.
Introduction
At least three polypeptide hormones have important roles to play in vertebrate calcium homeostasis, parathyroid hormone (Brown et al. 1987) , calcitonin (CT) (Copp et al. 1967) and stanniocalcin (STC) (Wagner 1994 , Chang et al. 1995 , Olsen et al. 1996 . Of these, CT in mammals and STC in fish share a common purpose (in spite of the fact that they are structurally unrelated and target entirely different tissues), namely the prevention of hypercalcemia. The secretion of both hormones is positively regulated by the prevailing levels of extracellular Ca 2+ (Anast & Conway 1972 , Gagel et al. 1980 , Wagner et al. 1989 , 1991 and both function as anti-hypercalcemic hormones in their respective vertebrate classes; CT in mammals through its inhibitory effects on osteoclastic bone resorption (Friedman & Raisz 1965 , Milhaud et al. 1965 , Aliapoulios et al. 1966 and STC in fish through its regulatory effects on Ca 2+ and phosphate transport by the gills, intestine and kidneys (Wagner 1994) . In comparison, the role of CT in fish is poorly understood. The CT-producing C cells in fish are much less responsive to the secretagogic effects of Ca 2+ than mammalian C cells (Roos et al. 1974) and there is no consensus as to the role of the hormone in calcium homeostasis (Wendelaar Bonga & Pang 1991) . The possibility of CT acting as a regulator of gill ion transport has received only limited attention to date, but early work on the isolated, perfused salmon gill has provided compelling evidence to suggest that the hormone is a potent inhibitor of gill Ca 2+ transport (GCAT) (Milhaud et al. 1977 , Milet et al. 1979 . To our knowledge, these studies have never been replicated in vivo. Therefore, in this report we have attempted to corroborate these findings by examining the effects of salmon CT on whole body 45 Ca uptake (as an in vivo measure of GCAT) in the rainbow trout. Our findings fully support this earlier work and suggest that both CT and STC work in concert to regulate GCAT.
Materials and Methods

Experimental materials and animals
Synthetic salmon CT was kindly supplied by Armour Pharmaceuticals, Inc., Kankakee, IL, USA. Fingerling rainbow trout (1-2 g) were obtained from Rainbow Springs Hatchery, Thamesford, Ontario, Canada, and maintained in recirculating dechlorinated tap water (12 C; 0·566 m Ca 2+ ) under a simulated natural photoperiod. The fish were fed once daily to satiation and starved 24 h prior to use.
The effects of salmon CT on GCAT in rainbow trout
A bioassay originally developed for testing the effects of the hormone STC was used (Wagner et al. 1997) . This bioassay monitors the effects of the hormone on whole body 45 Ca uptake which is considered to be a reliable indicator of GCAT in fish. For the present studies CT was used instead of STC, but otherwise the format of the bioassay was used as described (Wagner et al. 1997) .
For each experiment, four to six groups of 10 fingerling trout were given single i.p. injections of increasing amounts of CT dissolved in 0·4  sodium phosphate, such that each fish received a dose of CT (0·01-5·0 mg/kg) plus 99 mg/kg of elemental phosphate. The control group in each experiment received phosphate alone. The reason for phosphate-loading the fish in this manner is that this treatment significantly reduces plasma Ca 2+ and, as a consequence, plasma STC levels for up to 2 h in trout. The rate of GCAT in these fish rises significantly as a result of the lower plasma STC levels. Because of these effects, phosphate-loading heightens the sensitivity of trout to exogenous STC in terms of its ability to inhibit GCAT (Wagner et al. 1997) . As our working hypothesis was that CT would inhibit GCAT, we reasoned that it would be preferable to reduce as much as possible the influence of STC in order to best observe any inhibitory effects of CT on GCAT. Therefore, in all in vivo experiments the fish were phosphate-loaded at the same time as they received an injection of salmon CT. In each experiment, a sham-injected control group was always included along with the phosphate-loaded control group, to ensure that phosphate-loading had the desired effect (i.e. it caused a reduction in plasma STC levels and a rise in GCAT). A significant rise in GCAT in the phosphateloaded controls as compared with the shams was considered evidence of this.
After receiving their injections, each group of fish was placed in individual tanks of 45 Ca water. Two hours later the fish were euthanized in a 0·25% solution of benzocaine, washed in 0·1  HCl for 10 min to remove externally bound isotope, weighed and ashed overnight in crucibles at 600 C. The total isotope content of each fish was determined by scintillation counting of the dissolved ash. The rate of GCAT for each fish was calculated on the basis of the isotope content of the fish and the specific activity of the water and was expressed as µmol Ca 2+ /kg body weight per hour (Wagner et al. 1997) . The data from each experiment were subjected to ANOVA followed by Dunnet's test. Groups were considered to be significantly difference than the phosphate-injected controls at P<0·05.
The sham groups were used only to ensure the efficacy of phosphate-loading and were not included in the overall statistical analysis of each experiment.
The effects of salmon CT on STC secretion and STC mRNA levels
The possible effects of CT on STC secretion and gene expression were examined in primary cultured trout corpuscle of Stannius (CS) cells. The preparation, culturing and experimental use of these cells has already been described in detail (Ellis & Wagner 1995) . Briefly, freshly prepared CS cells from adult rainbow trout were seeded in Leibovitz L-15 medium (Leibovitz 1963 ) containing 10% fetal bovine serum plus antibiotics (100 U each of penicillin/streptomycin per ml) at a density of 0·5 10 6 cells/ml in 24 well plates. Cell viability was estimated to be >90% by trypan blue exclusion. The cells were maintained in a normal atmosphere at 15 C and allowed to attach for 3 days. Immediately prior to use, the cells were washed twice in serum free L-15 medium containing 0·1% bovine serum albumin to remove traces of fetal bovine serum and maintained in the same media for the duration of the experiment. Salmon CT was then added to cells from 100-fold concentrates to achieve the final desired concentrations (0·5, 5 and 50 ng/ml equivalent to 1·35 10 10 10 8  CT). Each concentration of CT was tested on triplicate wells of cells for periods of 1 and 3 days. Cells maintained in media without CT served as controls. After 1 and 3 days, the media were harvested and stored at 70 C for subsequent analysis of STC content by RIA (Wagner et al. 1991) . Total RNA was isolated from each well of cells according to Chomczynski and Sacchi (1987) and resolved on 1% agarose/formaldehyde gels. The resolved RNA was transferred to nylon membrane (Hybond N, Amersham, Canada) by capillary action and crosslinked by UV irradiation. Following a 2 h pre-hybridization period, the membrane was hybridized overnight sequentially to random-primed, 32 P-labeled salmon STC and 18S ribosomal RNA cDNAs as previously described (Ellis & Wagner 1995) under conditions of high stringency (50% formamide, 6 standard saline citrate (SSC), 1·25 Denhardt's solution, 100 µg/ml salmon sperm DNA, 0·1% SDS at 42 C). Blots were washed four times for 15 min in 2 SSC/0·1% SDS, followed by twice for 30 min in 0·1 SSC/0·1% SDS at 65 C. Following exposure to X-ray film, individual STC and 18S RNA bands were quantified by scanning densitometry and expressed as STC/18S mRNA ratios. These ratios were expressed as percentages for graphical display, using message levels in the control cells as the 100% baseline value. For statistical testing, the data were arcsine transformed and subjected to ANOVA followed by Dunnet's test, using the untreated cells as the controls. Groups were considered to be significantly different at P<0·05.
Results
The effects of salmon CT on GCAT in rainbow trout
Four dose-response experiments were conducted and the results are shown in Fig. 1 , where it can be seen that phosphate-loading was effective in raising GCAT in all four experiments, as in all cases the rate of GCAT significantly increased in phosphate-loaded controls as compared with shams. More importantly, CT significantly inhibited GCAT in all four experiments. However, the responsiveness of trout to the hormone was highly variable. Figure 1a and b show the results of the first two experiments, conducted 2 weeks apart (27 August and 10 September 1996), covering a dose range of 0·01-50 mg/kg body weight. In both studies CT significantly reduced GCAT, but over an extremely narrow range. In Experiment 1 (Fig. 1a) , both 0·01 and 0·05 mg/kg had significant inhibitory effects on GCAT that were doserelated and GCAT was lowered to the rate seen in sham-injected fish (22 and 44% reductions in GCAT respectively; P<0·05-0·01). Higher doses of the hormone were completely without effect (0·1-50 mg/kg). In Experiment 2, similar results were observed, although only the 0·05 mg/kg dose had a statistically significant effect on GCAT ( Fig. 1b ; 29% reduction in GCAT; P<0·01). Experiments 3 and 4 were conducted 1 day apart (20 and 21 August 1996) and covered a more narrow doseresponse range (0·01-1·0 mg/kg) but the fish were clearly less sensitive as greater amounts of CT were required to produce comparable inhibitory effects on GCAT. In Experiment 3 (Fig. 1c) , both 0·1 and 1·0 mg/kg of CT had highly significant inhibitory effects on GCAT (35 and 56% reductions in GCAT respectively; P<0·01), with the highest effective dose reducing GCAT to the rate seen in sham injected fish. When the same doses were tested in Experiment 4 (Fig. 1d) only the highest dose of CT had a significant effect on GCAT (1·0 mg/kg; 27% reduction in GCAT; P<0·01). Therefore in four successive experiments CT had inhibitory effects on GCAT, but the sensitivity of the trout population varied widely. 
The effects of salmon CT on STC secretion and STC mRNA levels
Figures 2 and 3 show the effects of salmon CT on STC secretion and gene expression, respectively. Figure 2 shows that the hormone had no discernible effects or trends, upwards or downwards, on STC secretion by cultured cells after 1 and 3 day exposures. Fig. 3a shows that CT had a marginal twofold effect on STC mRNA levels after 1 day (50 ng/ml; P<0·05) that was no longer evident after 3 days. The Northern blot of the 1 day CT exposure is shown in Fig. 3b .
Discussion
Since the discovery of CT in fish (Copp et al. 1967) , establishing a clear cut role for the hormone in calcium homeostasis has proven to be exceedingly difficult. Fish CT cells are much less responsive to changes in extracellular Ca 2+ levels than their mammalian counterparts (Roos et al. 1974) and there are poor correlations between plasma Ca 2+ and CT levels in fish (Watts et al. 1975 , Bjornsson & Deftos 1985 , Fouchereau-Peron et al. 1986 ). Furthermore, the earliest attempts to lower plasma Ca 2+ levels in cartilaginous and bony fish with salmon CT met with little success (Pang & Pickford 1967 , Louw et al. 1967 , Pang et al. 1974 . Since that time, however, several laboratories have been able to show that the fish hormone is indeed capable of altering plasma Ca 2+ levels in fish (Chan et al. 1968 , Lopez et al. 1976 , Wendelaar Bonga 1981 , Wales 1984 , Chakrabharti & Mukherjee 1993 . Nonetheless, inconclusive results are still reported from time to time and there is still no consensus as to the role of CT in fish (Wendelaar Bonga & Pang 1991) .
Several laboratories have reported that CT lowers plasma Ca 2+ levels in fish, and yet precisely how this is brought about has been addressed in very few studies. Lopez et al. (1976) attributed the reductions in plasma Ca 2+ levels in CT-treated eels to increased bone formation coupled with a reduction in osteoclast cell number and a reduction in osteoclastic bone resorption. Others have found the hypocalcemic response to be dependent on the levels of dissolved calcium in the surrounding water; in the sense that greater effects are obtained if the fish are held in low calcium water (Chakrabharti & Mukherjee 1993) , findings that directly implicate the gills and changes in GCAT as an integral part of the response. More compelling and direct evidence that CT is an inhibitor of GCAT comes from in vitro studies. Using the isolated, perfused salmon gill as a model for studies on GCAT, Milhaud et al. (1977) found that salmon CT decreased the rate of blood flow through the gill vasculature. The effects of CT were dose-related and, more importantly, were accompanied by a concomitant reduction in GCAT. It was concluded that the CT effect on GCAT was mediated through its effects on branchial blood flow. The estimated ED 50 for the CT response was at least 100-fold higher than circulating hormone levels in salmon (Milhaud et al. 1977) . However, it has since been argued that, as the ultimobranchial glands are close to the gills and because the CT gene is expressed in branchial as well as ultimobranchial tissue, the levels of hormone reaching the transporting epithelium could actually be much higher than those normally found in peripheral blood (Milhaud et al. 1977 , Martial et al. 1994 . Hence it was concluded that CT from both branchial and ultimobranchial sources could be mediating the transport of calcium by the gills (Milhaud et al. 1977) . Similar effects of CT on GCAT were subsequently observed in the isolated eel gill (Milet et al. 1979) .
Because the in vitro branchial effects of salmon CT had never been duplicated in vivo, we decided to test the effects of the hormone in a bioassay originally designed for STC, a hormone with well established inhibitory effects on GCAT. Surprisingly, our whole-animal studies completely support the central tenet of the in vitro findings (Milhaud et al. 1977 , Milet et al. 1979 , namely that salmon CT is capable of inhibiting GCAT. The gill perfusion studies suggested that the effects of CT were direct, as opposed to being mediated by the release of an additional regulatory factor. In the case of the present study, it is difficult if not impossible to conclude if the CT effects on GCAT were direct or otherwise. The hormone was obviously incapable of altering STC secretion, upwards or downwards, by cultured CS cells and so had no direct effects on STC output in vitro. However, the hormone may have stimulated STC secretion in vivo through alternative means, for instance by increasing plasma calcium levels. Several investigators have convincingly demonstrated that CT can raise calcium levels in fish (Glowacki et al. 1985 , Fouchereau-Peron et al. 1987 , Figure 2 The effects of salmon calcitonin on STC secretion by primary cultured trout CS cells. The cells were cultured as described in Material and Methods and exposed to graded concentrations of salmon calcitonin for 1 and 3 days. Calcitonin had no effects on STC secretion. Each histogram represents the mean S.E.M. of three wells of cells. Oughterson et al. 1995) , in complete contrast to the equally numerous studies showing the hypocalcemic effects of the hormone (Chan et al. 1968 , Lopez et al. 1976 , Wendelaar Bonga 1981 , Wales 1984 , Chakrabharti & Mukherjee 1993 . Therefore, in view of the contradictory nature of the evidence we cannot afford to ignore the possibility that CT injections may have raised plasma calcium levels as a means of stimulating STC secretion and reducing GCAT (although it is difficult to appreciate the logic of raising plasma calcium levels in order to lower them). At least one investigator has established what appears to be a convincing connection between STC and the actions of CT in fish. Chan et al. (1968) found that the hypocalcemic effect of CT in freshwater eels was completely abolished by stanniectomy, implying that the CS and by extension, STC, were responsible for mediating the CT effect. Therefore, the possibility that CT's effects are mediated in one way or another by STC should not be ruled out, at least until it has been proven that the hormone is just as incapable of altering STC levels in the whole animal as it is in primary cultured cells.
A final comment is warranted in relation to the variable responsiveness of trout to CT. Results such as these could easily be attributed to poor experimental technique were it not for the fact that they are so highly reminiscent of the variable responsiveness of trout at this very same stage of development to the effects of STC. Young trout undergo cyclical variations in the rate of GCAT that are controlled in part by reciprocal changes in plasma STC levels. Therefore, depending on when the hormone is administered, cycling trout can exhibit wide variations in their responsiveness to exogenous STC (Wagner et al. 1986 (Wagner et al. , 1988 (Wagner et al. , 1993 . With such a precedent at hand, it is not at all surprising that these animals would exhibit similar variations in their sensitivity to CT, especially if it too is a regulator of GCAT. In the case of CT, the underlying causes for variations in sensitivity could be concomitant changes in target tissue receptor numbers or, as in the case of STC, changes in endogenous hormone levels. We will have a much better understanding of the role of CT in fish when some of these issues are resolved. It is becoming increasingly apparent, however, that the transport of Ca 2+ across the fish gill is regulated in a complex fashion by a wide variety of hormonal systems.
In summary, we have provided in vivo confirmation of an earlier in vitro finding, namely that salmon CT is an inhibitor of GCAT in fish. Fish were variably responsive to the hormone but it is much too early to formulate conclusions as to the underlying causes. This will hopefully become apparent in future studies. The overall conclusion of our study is that CT and STC function in concert as negative regulators of GCAT in fish.
